RESUMO
The hydrogenation properties of Laves phases LnMg2 (Ln = La, Ce, Pr, Nd, Sm, Eu, Gd, Tb, Ho, Er, Tm, Yb) were investigated by thermal analysis, X-ray, synchrotron, and neutron powder diffraction. At 14.0 MPa hydrogen gas pressure and 393 K, PrMg2 and NdMg2 take up hydrogen and form the colorless, ternary hydrides PrMg2H7 (P41212, a = 632.386(6) pm, c = 945.722(11) pm) and NdMg2H7 (P41212, a = 630.354(9) pm, c = 943.018(16) pm). The crystal structures were refined by the Rietveld method from neutron powder diffraction data on the deuterides (PrMg2D7, P41212, a = 630.56(2) pm, c = 943.27(3) pm; NdMg2D7, P41212, a = 628.15(2) pm, c = 940.32(3) pm) and shown to be isotypic to LaMg2D7. The LaMg2D7 type of hydrides decompose at 695 K (La), 684 K (Ce), 684 K (Pr), 672 K (Nd), and 639 K (Sm) to lanthanide hydrides and magnesium. The Laves phase EuMg2 forms a hydride EuMg2Hx of black color. Its crystal structure (P212121, a = 664.887(4) pm, b = 1136.993(7) pm, c = 1069.887(7) pm) is closely related to the hexagonal Laves phase (MgZn2 type) of the hydrogen-free parent intermetallic. GdMg2 and TbMg2 form hydrides GdMg2Hx with orthorhombic unit cells (a = 1282.7(4) pm, b = 572.5(2) pm, c = 881.7(2) pm) and TbMg2Hx (a = 617.8(3) pm, b = 1045.8(8) pm, c = 997.1(5) pm), presumably also with a distorted MgZn2 type of structure. CeMg2H7 and NdMg2H7 are paramagnetic with effective magnetic moments of 2.49(1) µB and 3.62(1) µB, respectively, in good agreement with the calculated magnetic moments of the free trivalent rare-earth cations (µcalc(Ce3+) = 2.54 µB; µcalc(Nd3+) = 3.62 µB).
RESUMO
To elucidate the function of the transcriptional coregulator PRMT1 (protein arginine methyltranferase 1) in interferon (IFN) signaling, we investigated the expression of STAT1 (signal transducer and activator of transcription) target genes in PRMT1-depleted cells. We show here that PRMT1 represses a subset of IFNgamma-inducible STAT1 target genes in a methyltransferase-dependent manner. These genes are also regulated by the STAT1 inhibitor PIAS1 (protein inhibitor of activated STAT1). PIAS1 is arginine methylated by PRMT1 in vitro as well as in vivo upon IFN treatment. Mutational and mass spectrometric analysis of PIAS1 identifies Arg 303 as the single methylation site. Using both methylation-deficient and methylation-mimicking mutants, we find that arginine methylation of PIAS1 is essential for the repressive function of PRMT1 in IFN-dependent transcription and for the recruitment of PIAS1 to STAT1 target gene promoters in the late phase of the IFN response. Methylation-dependent promoter recruitment of PIAS1 results in the release of STAT1 and coincides with the decline of STAT1-activated transcription. Accordingly, knockdown of PRMT1 or PIAS1 enhances the anti-proliferative effect of IFNgamma. Our findings identify PRMT1 as a novel and crucial negative regulator of STAT1 activation that controls PIAS1-mediated repression by arginine methylation.
